| Name | Title | Contact Details |
|---|
Craig Medical Distribution is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mosaic is a whole-person healthcare organization reaching across 11 states and providing supports to more than 4,500 people. Services empower people with disabilities, mental and behavioral health needs and autism, as well as aging adults to live their best life. Mosaic is an affiliated social ministry organization of the Evangelical Lutheran Church in America and a member of Lutheran Services in America. Mosaic is a nonprofit 501(c)(3) organization.
At Carolina Pines Regional Medical Center, we "care for our own, right here at home." A leader in providing quality health care services to the people of several counties in northeastern South Carolina, patients have come to rely on our experienced, skilled staff and physicians to provide them with the highest level of care and compassion. Through the facilities on our campus, including a 116-bed acute care hospital and an adjoining medical office building, we provide comprehensive services with two things in mind: the care and comfort of our patients. From routine checkups to complex, state of the art surgery, Carolina Pines Regional Medical Center wants to be your health care provider of choice. Our goal is to be valued for our leadership, expertise and the ability to positively impact the quality of life for the citizens in our service area which includes Darlington, Chesterfield, Lee and Marlboro Counties. It is our privilege to care for our own, right here at home. This hospital is partially owned by physicians.
We support human resource departments and organizational workforces. From HR and benefits consulting services to health plan network management to benefits administration functions and processes, we support each and every aspect of a company's benefit
SCYNEXIS, Inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. Our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. We are developing our lead product candidate, SCY-078, a novel antifungal in Phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.